FDA Patient Safety Strategy Would Shift AE Monitoring To Automated Systems
Executive Summary
FDA plans to unveil a broad patient safety strategy over the next few months that will explain how the agency plans to move away from reliance on voluntary reporting to use of automated systems to collect adverse event and medical errors data
You may also be interested in...
PhRMA-FDA Working Group To Develop Best Practices For Data Mining
A Pharmaceutical Research & Manufacturers of America-FDA working group is looking at developing "best practices" for data mining techniques to identify potential safety signals
FDA Plan Seeks Better, Not Burdensome, Data Collection, McClellan Says
FDA Commissioner McClellan's strategic plan for the agency envisions "better," not "burdensome," information collection to inform risk management decisions
PhRMA-FDA Working Group To Develop Best Practices For Data Mining
A Pharmaceutical Research & Manufacturers of America-FDA working group is looking at developing "best practices" for data mining techniques to identify potential safety signals
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: